Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

The Genetic Landscape of DDX41 Gene Variants in Myeloid Neoplasms: A Large Single-Center Cohort Study from China

Li Qin, Yujiao Jia, Haoxu Wang, Xiaoxue Han, Shiqiang Qu, Huijun Wang, Qi Sun, Chengwen Li, Jigang Xiao, Hui Wei, Yingchang Mi, Jianxiang Wang, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 5717.

https://doi.org/10.1182/blood-2024-199897

Published: 2024

Journal Articles

Multiomics Characterization and Comprehensive Omics-Based Classification System in Adult Patients with B-Cell Acute Lymphoblastic Leukemia

Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi

Blood (2024) 144 (Supplement 1): 5908.

https://doi.org/10.1182/blood-2024-198988

Published: 2024

Journal Articles

Molecular Characteristics of Bone Marrow Mesenchymal Cells in Ph + Acute Lymphoblastic Leukemia and Their Protective Effects on Leukemia Cells

Yingchang Mi, Qiuyun Fang, Qishan Hao

Blood (2024) 144 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2024-207034

Published: 2024

Journal Articles

Thrombopoietin Receptor Agonist Added to Standard Immunosuppressive Therapy for Hepatitis-Associated Aplastic Anemia

Min Wang, Meili Ge, Liwei Fang, Liping Jing, Yingchang Mi, Fengkui Zhang, Yizhou Zheng, Jun Shi

Blood (2024) 144 (Supplement 1): 5687.

https://doi.org/10.1182/blood-2024-207385

Published: 2024

Journal Articles

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Wenjing Guo, Li Jia, Yingchang Mi, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7444.

https://doi.org/10.1182/blood-2024-210574

Published: 2024

Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) VS Venetoclax Combined with Azacitidine in Elderly Patients with Acute Myeloid Leukemia：a Phase III, Prospective, Multicenter, Randomized Controlled Trial

ZePing Zhou, Yaxian Tan, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Yunya Luo, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu

Blood (2024) 144 (Supplement 1): 6035.

https://doi.org/10.1182/blood-2024-202495

Published: 2024

Journal Articles

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Shuning Wei, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Wang Ying, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2812.

https://doi.org/10.1182/blood-2024-199109

Published: 2024

Journal Articles

The Therapeutic Effect of Myeloid-Suppressor Cells Induced By Umbilical Cord Blood CD34 + cells in Mice with Aplastic Anemia

Yilin Liu, Meili Ge, Yingchang Mi, Jinbo Huang

Blood (2024) 144 (Supplement 1): 1320.

https://doi.org/10.1182/blood-2024-210389

Published: 2024

Journal Articles

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Wenbing Liu, Yu Liu, Anli Lai, Runxia Gu, Ying Wang, Qing Rao, Yingchang Mi, Hui Wei, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2024-198599

Published: 2024

Journal Articles

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Blood (2024) 144 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2024-203422

Published: 2024

Journal Articles

Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation

Bingqing Huang, Yujiao Jia, Haoxu Wang, Huijun Wang, Qi Sun, Chengwen Li, Hui Wei, Yingchang Mi, Xiaofan Zhu, Jianxiang Wang, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 2842.

https://doi.org/10.1182/blood-2024-194421

Published: 2024

Journal Articles

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2024-198844

Published: 2024

Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine and Homoharringtonine (DEC3-VEN-HHT) As Induction Therapy in Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Lei Ju, Xingli Zhao, Xiaohui Suo, ZePing Zhou, Yanliang Bai, Yunya Luo, Sifeng Gao, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Yaxian Tan, Guanchen Bai, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu

Blood (2024) 144 (Supplement 1): 1505.

https://doi.org/10.1182/blood-2024-202971

Published: 2024

Journal Articles

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Blood (2024) 144 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2024-200713

Published: 2024

Journal Articles

Similar Efficacy and Distinct Safety Profile of Nilotinib, Dasatinib and Flumatinib in Chronic Myeloid Leukemia Patients Resistant or Intolerant to 1 st Line Imatinib

Bingcheng Liu, Ying Wang, Kaiqi Liu, Yan Li, Qiuyun Fang, Yuntao Liu, Xiaoyuan Gong, Chunlin Zhou, Benfa Gong, Guangji Zhang, Shaowei Qiu, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2024-204887

Published: 2024

Journal Articles

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) in the Treatment of Adult Patients with De Novo Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 4279.

https://doi.org/10.1182/blood-2024-202430

Published: 2024

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Blood (2023) 142 (Supplement 1): 2949.

https://doi.org/10.1182/blood-2023-185483

Published: 2023

Journal Articles

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

Shichong Wang, Jiali Huo, Yilin Liu, Lingyun Chen, Xiang Ren, Xingxin Li, Min Wang, Peng Jin, Jinbo Huang, Neng Nie, Jing Zhang, Yingqi Shao, Meili Ge, Yingchang Mi, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 2717.

https://doi.org/10.1182/blood-2023-178156

Published: 2023

Journal Articles

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem/Stromal Cell Death Via RIPK1-Independent Necroptosis

Xiang Ren, Meili Ge, Jiali Huo, Jinbo Huang, Min Wang, Yingqi Shao, Yingchang Mi, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 5624.

https://doi.org/10.1182/blood-2023-186067

Published: 2023

NARROW

The Genetic Landscape of DDX41 Gene Variants in Myeloid Neoplasms: A Large Single-Center Cohort Study from China

Multiomics Characterization and Comprehensive Omics-Based Classification System in Adult Patients with B-Cell Acute Lymphoblastic Leukemia

Molecular Characteristics of Bone Marrow Mesenchymal Cells in Ph + Acute Lymphoblastic Leukemia and Their Protective Effects on Leukemia Cells

Thrombopoietin Receptor Agonist Added to Standard Immunosuppressive Therapy for Hepatitis-Associated Aplastic Anemia

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) VS Venetoclax Combined with Azacitidine in Elderly Patients with Acute Myeloid Leukemia：a Phase III, Prospective, Multicenter, Randomized Controlled Trial

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

The Therapeutic Effect of Myeloid-Suppressor Cells Induced By Umbilical Cord Blood CD34 + cells in Mice with Aplastic Anemia

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Venetoclax Combined with Three-Day Multi-Frequency Decitabine and Homoharringtonine (DEC3-VEN-HHT) As Induction Therapy in Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Similar Efficacy and Distinct Safety Profile of Nilotinib, Dasatinib and Flumatinib in Chronic Myeloid Leukemia Patients Resistant or Intolerant to 1 st Line Imatinib

Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) in the Treatment of Adult Patients with De Novo Acute Myeloid Leukemia

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem/Stromal Cell Death Via RIPK1-Independent Necroptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only